Seminal plasma from 40 men attending an infertility clinic was analyzed for phospholipase A activity and compared with serum from 20 healthy blood donors. The imprecision of the method was acceptable and the overall coefficient of variation was 8.1 %. A huge discrepancy existed between seminal plasma and blood serum with regard to phospholipase A activity, the former fluid displaying on average a 180-fold higher activity than the latter. Preincubation of seminal plasma for 1 h at 37 °C resulted in an even higher phospholipase A activity while the corresponding activity in serum remained unchanged by such a treatment. This suggested the existence of a zymogen form of phospholipase A in seminal plasma. A significant correlation existed between sperm concentration and phospholipase A activity in seminal plasma (r = 0.46; p < 0.01) and preincubated seminal plasma samples from normozoospermic men displayed a significantly higher mean value than those of azoospermic men. Phospholipase A activity also correlated significantly to zinc concentration in seminal plasma (r = 0.67; p < 0.001). 4-Bromophenacyl bromide was inhibitory to a certain extent, the inhibition being most evident in the samples with high phospholipase A activity. Dibucaine and quinacrine, known phospholipase inhibitors in other systems, had no inhibitory effects. Only 58% of the seminal plasma samples contained measurable amounts of triglycerides. No significant correlation existed between triglyceride concentration and phospholipase A activity, r = 0.11.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.